Tirzepatide 20mg

Description

Tirzepatide 20mg is a high-purity, dual GIP and GLP-1 receptor agonist designed for metabolic and endocrine research applications.

Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has been engineered to also possess glucagon-like peptide-1 (GLP-1) receptor agonist activity. This dual-agonist profile makes it a significant subject of study in metabolic research. By targeting two distinct incretin pathways, researchers investigate its synergistic effects on insulin secretion, glucose metabolism, and lipid regulation compared to mono-receptor agonists. In laboratory settings, Tirzepatide is frequently utilized to examine the physiological responses of pancreatic beta cells and the modulation of gastric emptying rates. The 20mg concentration provides a robust baseline for longitudinal studies involving cellular signaling pathways and the biochemical mechanisms underlying energy homeostasis. All research conducted with this compound must be performed in vitro or within strictly controlled animal models.

Product Overview

Tirzepatide is a novel, dual GIP and GLP-1 receptor agonist designed for metabolic research. This compound is provided in a highly stable, lyophilised format to ensure structural integrity during laboratory experimentation. Research into this peptide focuses on its unique ability to interact with multiple hormone receptors simultaneously, providing insights into complex endocrine pathways.

Specifications

Form: Lyophilised Powder Quantity: 20mg per vial Purity: ≥99% (as confirmed by HPLC analysis) Storage: Store in a cool, dry place, away from direct light. For long-term stability, maintain at -20°C.

Research Applications

Current scientific literature explores Tirzepatide's role in enhancing glucose-dependent insulin secretion and its impact on glucagon levels. Researchers also study its influence on adipocyte metabolism and its potential to modulate hypothalamic signaling related to satiety and energy expenditure. It is a critical tool for understanding the cross-talk between GIP and GLP-1 receptors in metabolic health.

Research Use Notice

For laboratory research use only. Not for human or veterinary use.